Loading...
PPBT is not a good buy right now. The primary trend remains bearish (200/20/5-day MAs stacked bearishly), there are no proprietary buy signals today, no near-term news catalysts, and the pattern-based outlook skews modestly negative over 1W–1M. For an impatient trader unwilling to wait for a cleaner setup, the risk/reward is unfavorable at the current price area (~0.61).
Trend/structure: Bearish moving-average alignment (SMA_200 > SMA_20 > SMA_5) indicates the stock is still in a broader downtrend.
Momentum: MACD histogram is slightly positive (0.00128) but 'positively contracting,' suggesting weakening upside momentum rather than a strong reversal. RSI(6) at 34.8 is near the lower end of neutral/approaching oversold, implying selling pressure has been present but without a confirmed turn.
Levels: Pivot 0.629 is immediate overhead; price (0.6099) is below it, which is bearish. Key support sits at S1 0.595 then S2 0.574; resistance is R1 0.663 then R2 0.684. A decisive reclaim of ~0.629–0.663 would be needed to argue for a short-term trend change.
Near-term odds: Similar-pattern model indicates ~70% chance of small declines (-0.25% next day, -2.35% next week, -3.72% next month), reinforcing a cautious stance.

and then R1 (0.
could trigger a short-cover/mean-reversion bounce given RSI near the low end of neutral.
No news catalysts supporting a reversal right now.
Bearish trend persists (MA stack bearish) and MACD upside momentum is fading.
Model-based projection points to mild downside bias over the next week/month.
Hedge funds/insiders show neutral activity (no supportive accumulation signal).
Latest quarter: 2025/Q3. Revenue: 0 (0.00% YoY) — indicates no meaningful top-line traction in the reported period. Net income: -1.303M, 'up' 96.53% YoY (i.e., losses narrowed substantially), which is a positive directionally but still unprofitable. EPS: 0 (0.00% YoY as provided). Gross margin: 0 (0.00% YoY as provided). Overall: Improvements are mainly from reduced losses rather than growth; fundamentals do not provide an immediate buy-now catalyst.
No analyst rating or price target change data was provided, so a recent trend and Wall Street pro/con view cannot be reliably summarized from the dataset. Influential trading: No recent congress trading data available; no notable politician/influential buying/selling indicated.
Intellectia Proprietary Trading Signals:
